These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29497425)

  • 21. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.
    Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M
    Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRPM2 channels in alveolar epithelial cells mediate bleomycin-induced lung inflammation.
    Yonezawa R; Yamamoto S; Takenaka M; Kage Y; Negoro T; Toda T; Ohbayashi M; Numata T; Nakano Y; Yamamoto T; Mori Y; Ishii M; Shimizu S
    Free Radic Biol Med; 2016 Jan; 90():101-13. PubMed ID: 26600069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
    Zhao L; Mu B; Zhou R; Cheng Y; Huang C
    Int J Rheum Dis; 2019 Apr; 22(4):686-694. PubMed ID: 30666825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
    Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
    Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis.
    Barbosa-Matos C; Borges-Pereira C; Libório-Ramos S; Fernandes R; Oliveira M; Mendes-Frias A; Silvestre R; Osório NS; Bastos HN; Santos RF; Guimarães S; Morais A; Mazzone M; Carvalho A; Cunha C; Costa S
    Respir Res; 2024 Jun; 25(1):257. PubMed ID: 38909206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis.
    Kim MS; Kim SH; Jeon D; Kim HY; Lee K
    Toxicology; 2018 Jan; 393():185-192. PubMed ID: 29175452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
    Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
    PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice.
    Bale S; Sunkoju M; Reddy SS; Swamy V; Godugu C
    Indian J Pharmacol; 2016; 48(6):643-648. PubMed ID: 28066100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mizoribine protects against bleomycin-induced lung injury.
    Matsui K; Ueda H; Terada M; Azuma N; Okamura H; Sano H
    Mod Rheumatol; 2010 Oct; 20(5):471-7. PubMed ID: 20490597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise attenuates pulmonary injury in mice with bleomycin-induced pulmonary fibrosis.
    Prata LO; Oliveira FM; Ribeiro TM; Almeida PW; Cardoso JA; Rodrigues-Machado Mda G; Caliari MV
    Exp Biol Med (Maywood); 2012 Aug; 237(8):873-83. PubMed ID: 22903133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
    J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses.
    Zhu J; Kaplan AM; Goud SN
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1924-30. PubMed ID: 8665057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
    Okamoto A; Nojiri T; Konishi K; Tokudome T; Miura K; Hosoda H; Hino J; Miyazato M; Kyomoto Y; Asai K; Hirata K; Kangawa K
    Respir Res; 2017 Jan; 18(1):1. PubMed ID: 28049526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
    Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK
    Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.